 | • レポートコード：20QY06-04825 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、過活動膀胱薬のグローバル市場について種類別（抗コリン作用薬、ミラベグロン、ボトックス）、用途別（特発性過活動膀胱、神経性過活動膀胱）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・過活動膀胱薬市場の概要 ・世界の主要地域別過活動膀胱薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の過活動膀胱薬市場規模2015-2026：種類別（抗コリン作用薬、ミラベグロン、ボトックス） ・世界の過活動膀胱薬市場規模2015-2026：用途別（特発性過活動膀胱、神経性過活動膀胱） ・過活動膀胱薬の北米市場規模2015-2020 ・過活動膀胱薬のヨーロッパ市場規模2015-2020 ・過活動膀胱薬の中国市場規模2015-2020 ・過活動膀胱薬の日本市場規模2015-2020 ・過活動膀胱薬の東南アジア市場規模2015-2020 ・過活動膀胱薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （KYORIN Pharmaceutical、Astellas Pharma、Johnson & Johnson、Pfizer、Allergan） ・過活動膀胱薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・過活動膀胱薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Overactive Bladder Medication Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Overactive Bladder Medication market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Overactive Bladder Medication market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Overactive Bladder Medication industry.
Based on our recent survey, we have several different scenarios about the Overactive Bladder Medication YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Overactive Bladder Medication will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Overactive Bladder Medication market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Overactive Bladder Medication market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Overactive Bladder Medication market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Overactive Bladder Medication market. The report also includes nautical information, where it shows Overactive Bladder Medication market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Overactive Bladder Medication market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Overactive Bladder Medication market.
Geographical Analysis:
Based on region, the global Overactive Bladder Medication market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Overactive Bladder Medication market are
KYORIN Pharmaceutical
Astellas Pharma
Johnson & Johnson
Pfizer
Allergan
…
Segment by Type
Anticholinergics
Mirabegron
Botox
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Overactive Bladder Medication market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Overactive Bladder Medication market.
• The market share of the global Overactive Bladder Medication market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Overactive Bladder Medication market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Overactive Bladder Medication market.
1 Overactive Bladder Medication Market Overview
1.1 Overactive Bladder Medication Product Scope
1.2 Overactive Bladder Medication Segment by Type
1.2.1 Global Overactive Bladder Medication Sales by Type (2020-2026)
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.3 Overactive Bladder Medication Segment by Application
1.3.1 Global Overactive Bladder Medication Sales Comparison by Application (2020-2026)
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Overactive Bladder Medication Market Estimates and Forecasts (2015-2026)
1.4.1 Global Overactive Bladder Medication Sales Growth Rate (2015-2026)
1.4.2 Global Overactive Bladder Medication Revenue and Growth Rate (2015-2026)
1.4.3 Global Overactive Bladder Medication Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Overactive Bladder Medication Industry Impact
1.5.1 How the Covid-19 is Affecting the Overactive Bladder Medication Industry
1.5.1.1 Overactive Bladder Medication Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Overactive Bladder Medication Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Overactive Bladder Medication Players to Combat Covid-19 Impact
2 Overactive Bladder Medication Estimate and Forecast by Region
2.1 Global Overactive Bladder Medication Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Overactive Bladder Medication Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Overactive Bladder Medication Sales Market Share by Region (2015-2020)
2.2.2 Global Overactive Bladder Medication Revenue Market Share by Region (2015-2020)
2.3 Global Overactive Bladder Medication Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Overactive Bladder Medication Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Overactive Bladder Medication Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Overactive Bladder Medication Estimates and Projections (2015-2026)
2.4.2 Europe Overactive Bladder Medication Estimates and Projections (2015-2026)
2.4.3 China Overactive Bladder Medication Estimates and Projections (2015-2026)
2.4.4 Japan Overactive Bladder Medication Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Overactive Bladder Medication Estimates and Projections (2015-2026)
2.4.6 India Overactive Bladder Medication Estimates and Projections (2015-2026)
3 Global Overactive Bladder Medication Competition Landscape by Players
3.1 Global Top Overactive Bladder Medication Players by Sales (2015-2020)
3.2 Global Top Overactive Bladder Medication Players by Revenue (2015-2020)
3.3 Global Overactive Bladder Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder Medication as of 2019)
3.4 Global Overactive Bladder Medication Average Price by Company (2015-2020)
3.5 Manufacturers Overactive Bladder Medication Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Overactive Bladder Medication Players (Opinion Leaders)
4 Global Overactive Bladder Medication Market Size by Type
4.1 Global Overactive Bladder Medication Historic Market Review by Type (2015-2020)
4.1.1 Global Overactive Bladder Medication Sales Market Share by Type (2015-2020)
4.1.2 Global Overactive Bladder Medication Revenue Market Share by Type (2015-2020)
4.1.3 Global Overactive Bladder Medication Price by Type (2014-2020)
4.2 Global Overactive Bladder Medication Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Overactive Bladder Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Overactive Bladder Medication Revenue Forecast by Type (2021-2026)
4.2.3 Global Overactive Bladder Medication Price Forecast by Type (2021-2026)
5 Global Overactive Bladder Medication Market Size by Application
5.1 Global Overactive Bladder Medication Historic Market Review by Application (2015-2020)
5.1.1 Global Overactive Bladder Medication Sales Market Share by Application (2015-2020)
5.1.2 Global Overactive Bladder Medication Revenue Market Share by Application (2015-2020)
5.1.3 Global Overactive Bladder Medication Price by Application (2015-2020)
5.2 Global Overactive Bladder Medication Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Overactive Bladder Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Overactive Bladder Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Overactive Bladder Medication Price Forecast by Application (2021-2026)
3 North America Overactive Bladder Medication Market Facts & Figures
3.2 North America Overactive Bladder Medication Sales Market Share by Company (2015-2020)
3.3 North America Overactive Bladder Medication Sales Market Share by Type (2015-2020)
3.4 North America Overactive Bladder Medication Sales Market Share by Application (2015-2020)
4 Europe Overactive Bladder Medication Market Facts & Figures
4.2 Europe Overactive Bladder Medication Sales Market Share by Company (2015-2020)
4.3 Europe Overactive Bladder Medication Sales Market Share by Type (2015-2020)
4.4 Europe Overactive Bladder Medication Sales Market Share by Application (2015-2020)
5 China Overactive Bladder Medication Market Facts & Figures
5.2 China Overactive Bladder Medication Sales Market Share by Company (2015-2020)
5.3 China Overactive Bladder Medication Sales Market Share by Type (2015-2020)
5.4 China Overactive Bladder Medication Sales Market Share by Application (2015-2020)
6 Japan Overactive Bladder Medication Market Facts & Figures
6.2 Japan Overactive Bladder Medication Sales Market Share by Company (2015-2020)
6.3 Japan Overactive Bladder Medication Sales Market Share by Type (2015-2020)
6.4 Japan Overactive Bladder Medication Sales Market Share by Application (2015-2020)
7 Southeast Asia Overactive Bladder Medication Market Facts & Figures
7.2 Southeast Asia Overactive Bladder Medication Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Overactive Bladder Medication Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Overactive Bladder Medication Sales Market Share by Application (2015-2020)
8 India Overactive Bladder Medication Market Facts & Figures
8.2 India Overactive Bladder Medication Sales Market Share by Company (2015-2020)
8.3 India Overactive Bladder Medication Sales Market Share by Type (2015-2020)
8.4 India Overactive Bladder Medication Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Overactive Bladder Medication Business
12.1 KYORIN Pharmaceutical
12.1.1 KYORIN Pharmaceutical Overactive Bladder Medication Corporation Information
12.1.2 KYORIN Pharmaceutical Overactive Bladder Medication Business Overview and Total Revenue
12.1.3 KYORIN Pharmaceutical Overactive Bladder Medication Sales, Revenue and Gross Margin (2015-2020)
12.1.4 KYORIN Pharmaceutical Overactive Bladder Medication Products Offered
12.1.5 KYORIN Pharmaceutical Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Overactive Bladder Medication Corporation Information
12.2.2 Astellas Pharma Overactive Bladder Medication Business Overview and Total Revenue
12.2.3 Astellas Pharma Overactive Bladder Medication Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Astellas Pharma Overactive Bladder Medication Products Offered
12.2.5 Astellas Pharma Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Overactive Bladder Medication Corporation Information
12.3.2 Johnson & Johnson Overactive Bladder Medication Business Overview and Total Revenue
12.3.3 Johnson & Johnson Overactive Bladder Medication Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Overactive Bladder Medication Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Pfizer
12.4.1 Pfizer Overactive Bladder Medication Corporation Information
12.4.2 Pfizer Overactive Bladder Medication Business Overview and Total Revenue
12.4.3 Pfizer Overactive Bladder Medication Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Overactive Bladder Medication Products Offered
12.4.5 Pfizer Recent Development
12.5 Allergan
12.5.1 Allergan Overactive Bladder Medication Corporation Information
12.5.2 Allergan Overactive Bladder Medication Business Overview and Total Revenue
12.5.3 Allergan Overactive Bladder Medication Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Allergan Overactive Bladder Medication Products Offered
12.5.5 Allergan Recent Development
…
13 Overactive Bladder Medication Manufacturing Cost Analysis
13.1 Overactive Bladder Medication Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Overactive Bladder Medication
13.4 Overactive Bladder Medication Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Overactive Bladder Medication Distributors List
14.3 Overactive Bladder Medication Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Overactive Bladder Medication Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Overactive Bladder Medication Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Overactive Bladder Medication Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Overactive Bladder Medication Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Overactive Bladder Medication Players to Combat Covid-19 Impact
Table 8. Global Market Overactive Bladder Medication Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Overactive Bladder Medication Sales (K Units) by Region (2015-2020)
Table 10. Global Overactive Bladder Medication Sales Market Share by Region (2015-2020)
Table 11. Global Overactive Bladder Medication Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Overactive Bladder Medication Revenue Share by Region (2015-2020)
Table 13. Global Overactive Bladder Medication Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Overactive Bladder Medication Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Overactive Bladder Medication Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Overactive Bladder Medication Revenue Share Forecast by Region (2021-2026)
Table 17. Global Overactive Bladder Medication (K Units) of Key Companies (2015-2020)
Table 18. Global Overactive Bladder Medication Sales Share by Company (2015-2020)
Table 19. Global Overactive Bladder Medication Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Overactive Bladder Medication Revenue Share by Company (2015-2020)
Table 21. Global Overactive Bladder Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder Medication as of 2019)
Table 22. Global Overactive Bladder Medication Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Overactive Bladder Medication Manufacturing Sites and Area Served
Table 24. Manufacturers Overactive Bladder Medication Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Overactive Bladder Medication Players
Table 27. Global Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 28. Global Overactive Bladder Medication Sales Share by Type (2015-2020)
Table 29. Global Overactive Bladder Medication Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Overactive Bladder Medication Price (K Units) by Type (2015-2020)
Table 31. Global Overactive Bladder Medication Sales Share by Type (2021-2026)
Table 32. Global Overactive Bladder Medication Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Overactive Bladder Medication Revenue Share by Type (2021-2026)
Table 34. Global Overactive Bladder Medication Price (K Units) by Type (2021-2026)
Table 35. Global Overactive Bladder Medication Sales (K Units) by Application (2015-2020)
Table 36. Global Overactive Bladder Medication Sales Share by Application (2015-2020)
Table 37. Global Overactive Bladder Medication Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Overactive Bladder Medication Price (K Units) by Application (2015-2020)
Table 39. Global Overactive Bladder Medication Sales (K Units) by Application (2021-2026)
Table 40. Global Overactive Bladder Medication Sales Share by Application (2021-2026)
Table 41. Global Overactive Bladder Medication Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Overactive Bladder Medication Revenue Share by Application (2021-2026)
Table 43. Global Overactive Bladder Medication Price (K Units) by Application (2021-2026)
Table 44. United States Overactive Bladder Medication Sales (K Units) by Company (2015-2020)
Table 45. United States Overactive Bladder Medication Sales Market Share by Company (2015-2020)
Table 46. United States Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 47. United States Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 48. United States Overactive Bladder Medication Sales (K Units) by Application (2015-2020)
Table 49. United States Overactive Bladder Medication Sales Market Share by Application (2015-2020)
Table 50. Europe Overactive Bladder Medication Sales (K Units) by Company (2015-2020)
Table 51. Europe Overactive Bladder Medication Sales Market Share by Company (2015-2020)
Table 52. Europe Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 53. Europe Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 54. Europe Overactive Bladder Medication Sales (K Units) by Application (2015-2020)
Table 55. Europe Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 56. China Overactive Bladder Medication Sales (K Units) by Company (2015-2020)
Table 57. China Overactive Bladder Medication Sales Market Share by Company (2015-2020)
Table 58. China Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 59. China Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 60. China Overactive Bladder Medication Sales (K Units) by Application (2015-2020)
Table 61. China Overactive Bladder Medication Sales Market Share by Application (2015-2020)
Table 62. Japan Overactive Bladder Medication Sales (K Units) by Company (2015-2020)
Table 63. Japan Overactive Bladder Medication Sales Market Share by Company (2015-2020)
Table 64. Japan Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 65. Japan Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 66. Japan Overactive Bladder Medication Sales (K Units) by Application (2015-2020)
Table 67. Japan Overactive Bladder Medication Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Overactive Bladder Medication Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Overactive Bladder Medication Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Overactive Bladder Medication Sales Market Share by Application (2015-2020)
Table 74. India Overactive Bladder Medication Sales (K Units) by Company (2015-2020)
Table 75. India Overactive Bladder Medication Sales Market Share by Company (2015-2020)
Table 76. India Overactive Bladder Medication Sales (K Units) by Type (2015-2020)
Table 77. India Overactive Bladder Medication Sales Market Share by Type (2015-2020)
Table 78. India Overactive Bladder Medication Sales (K Units) by Application (2015-2020)
Table 79. India Overactive Bladder Medication Sales Market Share by Application (2015-2020)
Table 80. KYORIN Pharmaceutical Corporation Information
Table 81. KYORIN Pharmaceutical Description and Business Overview
Table 82. KYORIN Pharmaceutical Overactive Bladder Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. KYORIN Pharmaceutical Overactive Bladder Medication Product
Table 84. KYORIN Pharmaceutical Recent Development
Table 85. Astellas Pharma Corporation Information
Table 86. Astellas Pharma Description and Business Overview
Table 87. Astellas Pharma Overactive Bladder Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Astellas Pharma Overactive Bladder Medication Product
Table 89. Astellas Pharma Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Overactive Bladder Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Overactive Bladder Medication Product
Table 94. Johnson & Johnson Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Overactive Bladder Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Pfizer Overactive Bladder Medication Product
Table 99. Pfizer Recent Development
Table . Allergan Corporation Information
Table . Allergan Description and Business Overview
Table . Allergan Overactive Bladder Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Allergan Overactive Bladder Medication Product
Table . Allergan Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Overactive Bladder Medication Distributors List
Table 108. Overactive Bladder Medication Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Overactive Bladder Medication Product Picture
Figure 2. Global Overactive Bladder Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Overactive Bladder Medication Market Share by Application in 2020 & 2026
Figure 6. Idiopathic Overactive Bladder Examples
Figure 7. Neurogenic Overactive Bladder Examples
Figure 8. Global Overactive Bladder Medication Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Overactive Bladder Medication Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Overactive Bladder Medication Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Overactive Bladder Medication Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Overactive Bladder Medication Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Overactive Bladder Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Overactive Bladder Medication Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Overactive Bladder Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Overactive Bladder Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Overactive Bladder Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Overactive Bladder Medication Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Overactive Bladder Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Overactive Bladder Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Overactive Bladder Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Overactive Bladder Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Overactive Bladder Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Overactive Bladder Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Overactive Bladder Medication Players Market Share by Revenue in Overactive Bladder Medication 2015 & 2019
Figure 26. Overactive Bladder Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Overactive Bladder Medication Revenue Share by Type (2015-2020)
Figure 28. Global Overactive Bladder Medication Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Overactive Bladder Medication Revenue Share by Application (2015-2020)
Figure 30. Global Overactive Bladder Medication Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 32. United States Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 33. Europe Overactive Bladder Medication Sales Market Share by Company in 2019
Figure 34. Europe Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 35. Europe Overactive Bladder Medication Sales Market Share by Application in 2019
Figure 36. China Overactive Bladder Medication Sales Market Share by Company in 2019
Figure 37. China Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 38. China Overactive Bladder Medication Sales Market Share by Application in 2019
Figure 39. Japan Overactive Bladder Medication Sales Market Share by Company in 2019
Figure 40. Japan Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 41. Japan Overactive Bladder Medication Sales Market Share by Application in 2019
Figure 42. Southeast Asia Overactive Bladder Medication Sales Market Share by Company in 2019
Figure 43. Southeast Asia Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 44. Southeast Asia Overactive Bladder Medication Sales Market Share by Application in 2019
Figure 45. India Overactive Bladder Medication Sales Market Share by Company in 2019
Figure 46. India Overactive Bladder Medication Sales Market Share by Type in 2019
Figure 47. India Overactive Bladder Medication Sales Market Share by Application in 2019
Figure 48. KYORIN Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Overactive Bladder Medication
Figure 55. Manufacturing Process Analysis of Overactive Bladder Medication
Figure 56. Overactive Bladder Medication Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
低圧膀胱蓄圧器の世界市場レポート2020 The low pressure bladder accumulators consist of a welded pressure vessel, a flexible bladder with gas valve and a hydraulic connection with check valve or a perforated disc. Market Analysis and Insights: Global Low Pressure Bladder Accumulators Market The global Low Pressure Bladder Accumulators ma…- 低圧膀胱蓄圧器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Low Pressure Bladder Accumulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Low Pressur…
- 3D膀胱スキャナーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global 3D Bladder Scanners market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The 3D Bladder Scanners marke…
- 泌尿生殖器薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…
- 膀胱油圧アキュムレータの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bladder Hydraulic Accumulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bladder Hydrau…